Ibrutinib cancer drug molecule. Used in treatment of mantle cell lymphoma and chronic lymphocytic leukemia (CLL).


Ibrutinib cancer drug molecule. Used in treatment of mantle cell lymphoma and chronic lymphocytic leukemia (CLL). Stylized 2D rendering and conventional skeletal formula.


Size: 10786px × 4180px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: -cell, anticancer, antitumoral, atomic, atoms, btk, cancer, cell, chemical, chemistry, chronic, cll, cml, composition, disease, drug, generic, ibrutinib, ibrutinibe, kinase, leukemia, lymphocytic, lymphoma, malignancy, malignant, mantle, medicinal, medicine, model, molecular, molecule, myeloma, oncological, oncologist, oncology, pharma, pharmaceutical, pharmacology, pharmacy, phosphorylation, product, therapy, treatment, tumor, tyrosine